Picture of Daito Pharmaceutical Co logo

4577 Daito Pharmaceutical Co Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeSmall CapSuper Stock

Annual cashflow statement for Daito Pharmaceutical Co, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

2021
May 31st
2022
May 31st
2023
May 31st
2024
May 31st
2025
May 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoTanshin
Standards:
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5,8746,7205,0764,2182,958
Depreciation
Non-Cash Items105-17430-418-166
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-3,951-5,488-4,820-2,276-1,226
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities5,1834,3714,1565,1835,898
Capital Expenditures-6,350-4,733-5,556-6,276-7,095
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items25.3333-10346-270
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-6,324-4,400-5,566-5,930-7,365
Financing Cash Flow Items-0.00280-2-1-2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1,425989616-1831,002
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2891,008-774-879-519